Improving the Preclinical Mouse Efficacy Studies of Adenomyosis

In: Uterine Adenomyosis · 2015 · pp. 129–139 · doi:10.1007/978-3-319-13012-5_8 · W2302380492
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-10

Systematic review of preclinical mouse adenomyosis studies reveals methodological deficiencies that impede translational research, highlighting the need for improved rigor.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10

This paper reviews published preclinical mouse efficacy studies of adenomyosis, aiming to identify methodological deficiencies and propose ways to improve translational value for therapeutic development. It synthesizes evidence across animal study quality domains, highlighting both general animal-research criteria and adenomyosis-specific issues that may contribute to translational failure, noting that no novel adenomyosis therapeutics are currently in clinical evaluation. The paper explicitly frames the major caveat as the reliance on the systematic review of published studies, where heterogeneous reporting and methodological gaps limit confidence in what can be concluded from existing evidence. This paper is centrally about endometriosis and/or adenomyosis research— it is centrally about adenomyosis, specifically improving the methodology of preclinical mouse efficacy studies for translational therapeutic development.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (72)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK